Back
Skye Bioscience Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
53
SKYE
Skye Bioscience
Last Price:
4.96
Seasonality Move:
74.8%
Sell
38
NBY
NovaBay Pharmaceuticals
Last Price:
0.69
Seasonality Move:
-7.72%
Buy
53
Skye Bioscience (SKYE)
is a Buy
Is Skye Bioscience a Buy, Sell or Hold?
- The current Skye Bioscience [SKYE] share price is $5.51. The Score for SKYE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SKYE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.73. The Score for NBY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKYE Stock Price Chart
What is Skye Bioscience's stock price today?
-
The Skye Bioscience share price today is $5.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKYE is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
SKYE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 58.94 | Buy |
| Chaikin Money Flow: | 6656 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.49 - 5.53) | Buy |
| Bollinger Bands (100): | (4.34 - 6.48) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 55.4 | Buy |
| Chaikin Money Flow: | 14807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.73) | Buy |
| Bollinger Bands (100): | (0.28 - 1.6) | Sell |
SKYE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.45 | Buy |
| 20-day SMA: | 5.23 | Buy |
| 50-day SMA: | 4.85 | Buy |
| 200-day SMA: | 8.38 | Sell |
| 8-day EMA: | 5.42 | Buy |
| 20-day EMA: | 5.19 | Buy |
| 50-day EMA: | 5.15 | Buy |
| 200-day EMA: | 6.5 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.72 | Buy |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 0.63 | Buy |
| 200-day SMA: | 2.47 | Sell |
| 8-day EMA: | 0.72 | Buy |
| 20-day EMA: | 0.69 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 5.87 | Sell |
Skye Bioscience Earnings Growth & SKYE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $0.18 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Skye Bioscience Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||